14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $84.70 $93.35 Wednesday, 24th Apr 2024 BMRN stock ended at $91.20. This is 0.93% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 2.20% from a day low at $91.01 to a day high of $93.02.
90 days $83.44 $94.15
52 weeks $76.02 $99.55

Historical BioMarin Pharmaceutical Inc. prices

Date Open High Low Close Volume
Sep 24, 2020 $77.40 $78.00 $75.02 $76.58 2 584 213
Sep 23, 2020 $79.38 $80.24 $78.09 $78.43 1 898 418
Sep 22, 2020 $77.39 $80.94 $75.41 $79.36 2 708 605
Sep 21, 2020 $78.56 $78.63 $76.71 $77.28 2 165 510
Sep 18, 2020 $78.81 $79.72 $77.18 $79.38 4 328 750
Sep 17, 2020 $74.84 $78.64 $74.12 $78.36 3 073 574
Sep 16, 2020 $75.50 $76.39 $75.09 $75.64 1 645 791
Sep 15, 2020 $75.94 $76.10 $74.64 $75.51 1 528 711
Sep 14, 2020 $72.99 $76.14 $72.99 $75.34 2 449 880
Sep 11, 2020 $72.60 $73.24 $71.35 $72.05 2 252 272
Sep 10, 2020 $74.11 $75.15 $71.50 $71.87 3 241 729
Sep 09, 2020 $75.45 $75.63 $73.87 $74.49 2 669 454
Sep 08, 2020 $74.72 $75.72 $73.70 $74.49 1 612 028
Sep 04, 2020 $75.74 $76.64 $73.76 $76.00 2 266 988
Sep 03, 2020 $77.74 $77.83 $75.39 $75.84 2 556 312
Sep 02, 2020 $76.73 $78.86 $76.12 $77.99 2 170 889
Sep 01, 2020 $77.85 $78.04 $75.56 $76.00 2 290 227
Aug 31, 2020 $76.57 $79.00 $76.54 $78.03 3 031 653
Aug 28, 2020 $75.99 $76.44 $74.80 $76.38 1 765 152
Aug 27, 2020 $74.78 $77.24 $74.24 $75.43 4 067 073
Aug 26, 2020 $73.86 $75.32 $73.70 $74.89 2 544 793
Aug 25, 2020 $74.17 $75.00 $73.29 $74.40 3 196 197
Aug 24, 2020 $75.46 $75.65 $72.24 $73.00 3 853 950
Aug 21, 2020 $74.80 $75.74 $73.88 $75.03 5 583 973
Aug 20, 2020 $76.27 $76.73 $74.60 $74.85 7 284 745
Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT